↓ Skip to main content

Disruptive Psychopharmacology

Overview of attention for book
Disruptive Psychopharmacology
Springer International Publishing

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 266 Foundations for Training Psychedelic Therapists.
  3. Altmetric Badge
    Chapter 267 Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms
  4. Altmetric Badge
    Chapter 268 Psychedelic Group Therapy
  5. Altmetric Badge
    Chapter 269 Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults
  6. Altmetric Badge
    Chapter 270 Dosing Psychedelics and MDMA
  7. Altmetric Badge
    Chapter 277 Ayahuasca for the Treatment of Depression
  8. Altmetric Badge
    Chapter 278 The Potential of Psychedelics for End of Life and Palliative Care
  9. Altmetric Badge
    Chapter 279 Psilocybin for the Treatment of Obsessive-Compulsive Disorders
  10. Altmetric Badge
    Chapter 282 Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach
  11. Altmetric Badge
    Chapter 284 Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.
  12. Altmetric Badge
    Chapter 298 Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature
  13. Altmetric Badge
    Chapter 313 Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics
  14. Altmetric Badge
    Chapter 327 Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation
  15. Altmetric Badge
    Chapter 365 Psychedelics in the Treatment of Headache and Chronic Pain Disorders
  16. Altmetric Badge
    Chapter 366 Psilocybin for Trauma-Related Disorders
  17. Altmetric Badge
    Chapter 367 Psychedelics and Anti-inflammatory Activity in Animal Models
Attention for Chapter 327: Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news
1 news outlet
twitter
28 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation
Chapter number 327
Book title
Disruptive Psychopharmacology
Published in
Current topics in behavioral neurosciences, January 2022
DOI 10.1007/7854_2022_327
Pubmed ID
Book ISBNs
978-3-03-112183-8, 978-3-03-112184-5
Authors

Johnson, Matthew W.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 28 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 13%
Researcher 4 9%
Student > Ph. D. Student 3 7%
Student > Doctoral Student 2 4%
Other 2 4%
Other 4 9%
Unknown 25 54%
Readers by discipline Count As %
Psychology 5 11%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Neuroscience 3 7%
Medicine and Dentistry 3 7%
Biochemistry, Genetics and Molecular Biology 2 4%
Other 2 4%
Unknown 28 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2023.
All research outputs
#1,510,426
of 26,582,041 outputs
Outputs from Current topics in behavioral neurosciences
#56
of 528 outputs
Outputs of similar age
#36,814
of 532,562 outputs
Outputs of similar age from Current topics in behavioral neurosciences
#6
of 33 outputs
Altmetric has tracked 26,582,041 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 528 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.3. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 532,562 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.